Vanguard U.S. Opportunities Fund Investor GBP Income

Name
Vanguard U.S. Opportunities Fund Investor GBP Income
Manager
Vanguard Group (Ireland) Limited
Type
Open Ended Investment Company
ISIN
IE00B1GHC616
Sector
North America
Launched
19/12/2006
OCF
0.95 %
Risk Rating
4
3 Year Sharpe
0.45
3 Year Alpha
-4.07
Yield
0 %
Benchmark
Russell 3000 NR USD
This actively managed fund seeks to provide long-term capital growth by investing in U.S. stocks with above-average earnings growth potential that is not reflected in current market prices.
Holding %
Eli Lilly and Co 4.91 %
Abiomed Inc 2.73 %
Seattle Genetics Inc 2.56 %
Biomarin Pharmaceutical Inc 2.24 %
Southwest Airlines Co 2.09 %
Alibaba Group Holding Ltd ADR 1.92 %
Nektar Therapeutics 1.81 %
Micron Technology Inc 1.78 %
Biogen Inc 1.78 %
Charles Schwab Corp 1.63 %
Region %
United States 87.74 %
Sector %
Healthcare 36.11 %
Technology 22.65 %
Industrials 15.75 %
Financial Services 11.25 %
Consumer Cyclical 7.98 %
Name
Vanguard Group (Ireland) Limited
Address
2, Dublin, Ireland
UCITS
Yes
Legal Structure
Open Ended Investment Company

Managers

Not Disclosed
Joined 04/08/2002

Data provided by Morningstar.

The Content is only for your general information and use and is not intended to address your particular requirements. The Content does not constitute any form of advice, recommendation or arrangement by Money Observer and is not intended to be relied upon by you in making (or refraining from making) any specific investment or other decisions. Appropriate independent advice should be obtained before making any such decision.

This information is sourced from our partner Morningstar. We believe the data to be correct however you should take care in using any information.

You should be aware that prices may fall as well as rise and that the income derived can go down as well as up. When buying or selling any investment that fluctuates in price or value you may get back less than you invested. Past performance is not necessarily a guide to future performance.